REQUEST A DEMO
Total
USD $0.00
Search more companies

Unimed Pharma, Spol. S R.O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Unimed Pharma, Spol. S R.O. Profile Updated: October 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Unimed Pharma, Spol. S R.O. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 16, 1994. There are currently 50 - 99 (2023) people employed by Unimed Pharma, Spol. S R.O.. The latest financial highlights indicate a net sales revenue increase of 15.52% in 2023. Its’ total assets recorded a growth of 19.51%. In 2023, Unimed Pharma, Spol. S R.O.’s net profit margin increased by 3.85%.

Headquarters
Orieskova, 11
Bratislava; Bratislavsky; Postal Code: 82105

Contact Details: Purchase the Unimed Pharma, Spol. S R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Unimed Pharma, Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Unimed Pharma, Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Unimed Pharma, Spol. S R.O. report to view the information.
Incorporation Date:
February 16, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Unimed Pharma, Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.52%
Total operating revenue
17.52%
Operating profit (EBIT)
84.01%
EBITDA
64.89%
Net Profit (Loss) for the Period
143.61%
Total assets
19.51%
Total equity
6.69%
Operating Profit Margin (ROS)
5.75%
Net Profit Margin
3.85%
Return on Equity (ROE)
3.52%
Debt to Equity Ratio
-0.01%
Quick Ratio
-6.24%
Cash Ratio
-5.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?